Effect of Xen Implantation on the Aqueous Humor Proteome

Price Vision Group3 enrolled

Overview

The purpose of this study is to determine how the aqueous humor proteome changes after implantation of a Xen microstent for treatment of glaucoma.

The purpose of this study is to determine how the aqueous humor proteome changes after implantation of a Xen microstent for treatment of glaucoma using liquid chromatography mass spectrometry.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Primary Open Angle Glaucoma

Interventions

XenDEVICE

Xen microstent implantation

Aqueous shuntDEVICE

Aqueous shunt implantation

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female of any racial or ethnic origin, 18 years or older * Able to provide written informed consent. * Scheduled to undergo Xen implantation for open angle glaucoma or already has an aqueous shunt Exclusion Criteria: * History of conjunctivitis or any ocular infection within the past 3 weeks. * Any active inflammation of the cornea or the anterior chamber (uveitis)

Locations (1)

Price Vision Group

Indianapolis, Indiana, United States

Outcomes

Primary Outcomes

Aqueous humor proteome

The aqueous humor proteome will be assessed with liquid chromotography/mass spectometry (quantitative LC-MS/MS).

Time frame: Change from baseline at 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.